相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/ Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)
et al.
CIRCULATION (2011)
Standardized Bleeding Definitions for Cardiovascular Clinical Trials A Consensus Report From the Bleeding Academic Research Consortium
Roxana Mehran et al.
CIRCULATION (2011)
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial
Gregg W. Stone et al.
LANCET (2011)
Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention
Dirk Sibbing et al.
EUROPEAN HEART JOURNAL (2008)
Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions -: Appropriateness of including bleeding as a component of a quadruple end point
Gjin Ndrepepa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Bivalirudin versus unfractionated heparin during percutaneous coronary intervention
Adnan Kastrati et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Bivalirudin during primary PCI in acute myocardial infarction
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial
Gregg W. Stone et al.
LANCET (2007)
Stent thrombosis in randomized clinical trials of drug-eluting stents
Laura Mauri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Bivalirudin for patients with acute coronary syndromes
Gregg W. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Outcomes of patients with acute coronary syndromes who are treated with bivalirudin during percutaneous coronary intervention: An analysis from the Randomized Evaluation in PCI Linking Angiomax to Reduced Clinical Events (REPLACE-2) trial
Vivek Rajagopal et al.
AMERICAN HEART JOURNAL (2006)
Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment -: The ISAR-REACT 2 randomized trial
A Kastrati et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel
A Kastrati et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel
J Mehilli et al.
CIRCULATION (2004)
Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention - REPLACE-2 Randomized Trial
AM Lincoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting
FJ Neumann et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)